Lidocaine Hydrochloride Injection, Solution
Product Images NDC 55150-163

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 55150-163). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1% 20 mg/2 mL (10 mg/mL))

Label for Lidocaine Hydrochloride Injection USP 1% (20 mg/2 mL, 10 mg/mL) preservative-free single dose vial. It indicates the vial volume is 2 mL and for infiltration and nerve block including caudal and epidural use. The label also notes it can be resterilized by autoclaving and warns against use if discolored or containing precipitate. Manufactured in India for AuroMedics Pharma LLC, Windsor, NJ.*

FDA Label Image

Package Label-principal Display Panel (2% 100 mg/5 mL (20 mg/mL))

Packaging label for Lidocaine HCl Injection USP 2% (20 mg/mL) solution, indicated for infiltration and nerve block including caudal and epidural use. The label shows a box holding 10 vials of 5 mL each, preservative-free and sterile. Distributed by Auromedics Pharma LLC, the label includes dosage and storage information along with a barcode and NDC 55150-165-05.*

FDA Label Image

Package Label-principal Display Panel (1% 20 mg/2 mL (10 mg/mL))

Packaging label for Lidocaine Hydrochloride Injection, USP 1% (10 mg/mL) by Auromedics Pharma LLC. The label states "For Infiltration and Nerve Block Including Caudal and Epidural Use," preservative-free, sterile, nonpyrogenic. The package contains 10 single-dose vials, each 2 mL. Manufacturer is noted as Auromedics, made in India. NDC 55150-161-02 is displayed along with barcode and usage/storage instructions.*

FDA Label Image

Package Label-principal Display Panel (1% 50 mg/5 mL (10 mg/mL))

Lidocaine Hydrochloride Injection USP 1% (10 mg/mL) in a 5 mL single-dose vial. The label states it is preservative-free and intended for infiltration and nerve block, including caudal and epidural use. The product is sterile, nonpyrogenic, and manufactured in India for AuroMedics Pharma LLC.*

FDA Label Image

Package Label-principal Display Panel (1% 50 mg/5 mL (10 mg/mL))

Packaging label for Lidocaine HCl Injection, USP 1% (10 mg/mL) by Auromedics, containing 10 x 5 mL single-dose vials. The sterile, nonpyrogenic, preservative-free injection is indicated for infiltration and nerve block including caudal and epidural use. The label includes ingredients, usage warnings, and storage instructions, with NDC 55150-162-05.*

FDA Label Image

Package Label-principal Display Panel (1% 300 mg/30 mL (10 mg/mL))

Label of Lidocaine Hydrochloride Injection, USP, 1% (10 mg/mL) in a 30 mL single-dose vial. The product is preservative-free and intended for infiltration and nerve block including caudal and epidural use. Distributed by AuroMedics Pharma LLC, made in India, with storage instructions and sterility details included.*

FDA Label Image

Package Label-principal Display Panel (1% 300 mg/30 mL (10 mg/mL))

Packaging label for Lidocaine Hydrochloride Injection, USP 1% (10 mg/mL) solution in a 30 mL single dose vial. The label indicates it is preservative-free and intended for infiltration and nerve block, including caudal and epidural use. Distributed by AuroMedics Pharma LLC, made in India, with an NDC of 55150-163-30. Additional details include sterile, nonpyrogenic status and ingredient information.*

FDA Label Image

Package Label-principal Display Panel (2% 40 mg/2 mL (20 mg/mL))

Label for Lidocaine Hydrochloride Injection, USP, 2% (20 mg/mL) solution in a 2 mL single dose vial. The label indicates the product is preservative-free and intended for infiltration and nerve block including caudal and epidural use. Manufactured in India for AuroMedics Pharma LLC, distributed by Eugia US LLC.*

FDA Label Image

Package Label-principal Display Panel (2% 40 mg/2 mL (20 mg/mL))

Packaging label for Lidocaine HCl Injection, USP 2% (20 mg/2 mL) preservative-free solution, indicated for infiltration and nerve block including caudal and epidural use. The label shows a package of 10 single-dose vials of 2 mL each. Distributed by Auromedics Pharma LLC, made in India, sterile and nonpyrogenic.*

FDA Label Image

Package Label-principal Display Panel (2% 100 mg/5 mL (20 mg/mL))

Lidocaine Hydrochloride Injection, USP 20 mg/mL (2%), 5 mL single-dose vial label by Eugia US LLC. The vial is preservative-free and intended for infiltration and nerve block including caudal and epidural use. The label includes storage instructions and manufacturer details.*

FDA Label Image

Lidocaine Hydrochloride Chemical Structure (Lidocaine Str)

Chemical structure of Lidocaine Hydrochloride, showing the molecular arrangement including the aromatic ring with two methyl groups, amide linkage, and tertiary amine with ethyl groups, along with associated hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.